Compare PRGO & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRGO | STEW |
|---|---|---|
| Founded | 1887 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2013 | 1996 |
| Metric | PRGO | STEW |
|---|---|---|
| Price | $14.76 | $18.67 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.33 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 79.0K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.23 | $16.55 |
| 52 Week High | $23.98 | $19.05 |
| Indicator | PRGO | STEW |
|---|---|---|
| Relative Strength Index (RSI) | 73.63 | 56.56 |
| Support Level | $9.59 | $18.31 |
| Resistance Level | $15.08 | $19.05 |
| Average True Range (ATR) | 0.51 | 0.19 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 97.18 | 49.40 |
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.